THE ASSOCIATION OF DURATION OF TYPE 2 DIABETES MELLITUS WITH THE PREVALENCE OF PERIPHERAL DIABETIC NEUROPATHY

Nixie Sabari, Prettsun Ang Mellow, Franklin Vinsentius Malonda

Abstract


Background: Chronic complications of diabetes mellitus have a significant role in increased morbidity, mortality, disability, and health cost as the population increases every year. Promotive and preventive actions are needed to decrease the prevalence of peripheral diabetic neuropathy. The screening tool for peripheral diabetic neuropathy is Michigan Neuropathy Screening Instrument (MNSI), which consists questionnaire and physical examination.
Objective: The purpose of this study was to understand the association of the duration of type 2 diabetes mellitus with the prevalence of peripheral diabetic neuropathy in the Outpatient Unit of Gotong Royong Hospital Surabaya. Method: A cross-sectional study was done using 50 patients in the Outpatient Unit of Gotong Royong Hospital Surabaya. The sampling technique used consecutive sampling with filling out the Michigan Neuropathy Screening Instrument (MNSI) questionnaire. The score of the MNSI questionnaire is analyzed using Chi-Square Test.
Result: Among 50 subjects who participated in the study, most were women (78%). The prevalence of patients with peripheral diabetic neuropathy was 28% from all subjects. This chronic complication is divided into two groups based on the duration of diabetes mellitus type 2 with the prevalence of peripheral diabetic neuropathy with a duration of diabetes <5 years (18,2%) and peripheral diabetic neuropathy with the duration of diabetes more than equal to five years old (35,7%). From the analysis with Chi-Square, we did not find a significant association between the duration of type 2 diabetes mellitus and peripheral diabetic neuropathy (p = 0.004).
Conclusion: There was no statistically significant association between the duration of type 2 diabetes mellitus and the prevalence of peripheral diabetic neuropathy.


Save to Mendeley


Keywords


Type 2 Diabetes Mellitus; Peripheral Diabetic Neuropathy; Michigan Neuropathy Screening Instrument (MNSI)

Full Text:

PDF

References


Del Michael A. Core, Ahn Junho, B. Robert et al. The evaluation and treatment of diabetic foot ulcers and diabetic foot infections. Foot & Ankle Orthopaedics 3(3). 2018. Available from : https://doi.org/10.1177/2473011418788864

International Diabetes Federation. IDF Diabetes Atlas 9th Edition; 2019.

Kementrian kesehatan RI. Pusat data dan informasi kementrian kesehatan RI; 2018. Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&ved=2ahUKEwi92MagqKvoAhVBeysKHTlzCYwQFjACegQIDBAF&url=https%3A%2F%2Fpusdatin.kemkes.go.id%2Fdownload.php%3Ffile%3Ddownload%2Fpusdatin%2Finfodatin%2Finfodatin-Diabetes-2018.pdf&usg=AOvVaw0kSq_S4zRFPUwj4jHS38_3

Riskesdas-kesmaskemkes. Available from : http://www.kesmas.kemkes.go.id/assets/upload/dir_519d41d8cd98f00/files/Hasil-riskesdas-2018_1274.pdf

PERKENI. Konsensus. Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. 2015. Available from: https://pbperkeni.or.id/wp-content/uploads/2019/01/4.-Konsensus-Pengelolaan-dan-Pencegahan-Diabetes-melitus-tipe-2-di-Indonesia-PERKENI-2015.pdf

Juster-Switlyk K, Smith AG. Updates in diabetic peripheral neuropathy. F1000Res. 2016 Apr 25;5:F1000 Faculty Rev-738. Available from : https://doi.org/10.12688/f1000research.7898.1

American Diabetes Association, 2018. Microvascular complications and foot care: standards of medical care in diabetes;41(Suppl. 1):S105–S118. Available from: https://doi.org/10.2337/dc18-S010

Made I Nasar, Cornain Santoso. Buku ajar patologi robbins. Edisi 9. 2015

Abuse Mona Ali, Elmasry Hatem Anwar, Oraby Mohammed Ibrahim et al. Gender differences in diabetic peripheral neuropathy. Egyptian Journal of Medical Research (EJMR) vol 1, issue 1. 2020. Available from: https://ejmr.journals.ekb.eg/article_89059_7e035a8fe6b2c516307200a31325e21a.pdf

Popescu Simona, Timar Bogdan, Baderca Flavia et al. Age as anan independent factor for the development of neuropathy in diabetic patients. Clin Interv Aging. 2016;11:313-318. 2016. Available from: https://doi.org/10.2147/CIA.S97295

Nisar Muhammad Umer, Asad Ambreen, Waqas Ahmed et al. Association of diabetic neuropathy with duration of type 2 diabetes and glycemic control. 2015 Aug 12;7(8):e302. Available from: https://doi.org/ 10.7759/cureus.302

Pham Vuong, Matsumura Shinji, Katano Tayo. Diabetic neuropathy research: from mouse models to targets for treatment. Neural Regen Ressearch. 2019 Nov; 14(11): 1870–1879. Available from: : https://doi.org/10.4103/1673-5374.259603

Ristikj-Stomnaroska Daniela, Risteka-Nejashmikj Valentina, Papazova Marija. Role of inflammation in the pathogenesis of diabetic peripheral neuropathy. Macedonian Journal of Medical Science. 2019 Jul 30; 7(14): 2267–2270. Available from: https://doi.org/10.3889/oamjms.2019.646




DOI: https://doi.org/10.33508/jwmj.v4i2.3797

Refbacks

  • There are currently no refbacks.